Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake

Page 5 of 10

Page 5 of 10 – SEC Filing
CUSIP
No.  016259103
13G Page
5 of 9 Pages
Item 1.
(a)

Name of Issuer

Alimera Sciences Inc.

(b)

Address of Issuer’s
Principal Executive Offices

6120 Windward Parkway, Suite 290, Alpharetta, GA 30005

Item 2.
(a)

Name of Person Filing

Great Point Partners, LLC
Dr. Jeffrey R. Jay, M.D.

Mr. David Kroin

The Reporting Persons have entered into a Joint Filing Agreement, dated August 22, 2016, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this statement jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act.

(b)

Address of Principal Business Office, or if none, Residence

The address of the principal business
office of each of the Reporting Persons is

165 Mason Street, 3rd Floor
Greenwich, CT 06830

(c)

Citizenship

Great Point Partners, LLC is a limited liability company organized under the laws of the State of Delaware. Dr. Jeffrey R. Jay, M.D. is a citizen of the United States. Mr. David Kroin is a citizen of the United States.

(d)

Title of Class of Securities

Common Stock

(e)

CUSIP Number

016259103

Item 3. If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
Not Applicable.
(a) o Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o)
(b) o Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) o Insurance company as defined in Section 3(a)(19) of the Act (15. U.S.C. 78c).
(d) o Investment Company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
(e) o An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
(f) o An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).

Follow Alimera Sciences Inc (NASDAQ:ALIM)

Page 5 of 10